[PDF][PDF] Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of …

Z Li, Z Ma, Q Zhou, S Wang, Q Yan, H Zhuang, Z Zhou… - Heliyon, 2022 - cell.com
Background Although some improvements in the management of pancreatic cancer (PC)
have been made, no major breakthroughs in terms of biomarker discovery or effective …

Identification By Genetic Algorithm Optimized Back Propagation Artificial Neural Network and Validation of A Four-Gene Signature for Diagnosis and Prognosis of …

Z Li, S Huang, Z Ma, D Xia, Y Cai, J Wu, H Zhuang… - 2021 - researchsquare.com
Background: Although some improvements in the management of pancreatic cancer (PC)
have been made, no major breakthroughs in terms of biomarker discovery or effective …

[HTML][HTML] Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of …

Z Li, Z Ma, Q Zhou, S Wang, Q Yan, H Zhuang, Z Zhou… - Heliyon, 2022 - Elsevier
Background Although some improvements in the management of pancreatic cancer (PC)
have been made, no major breakthroughs in terms of biomarker discovery or effective …

Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of …

Z Li, Z Ma, Q Zhou, S Wang, Q Yan, H Zhuang… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Although some improvements in the management of pancreatic cancer (PC)
have been made, no major breakthroughs in terms of biomarker discovery or effective …

Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of …

Z Li, Z Ma, Q Zhou, S Wang, Q Yan, H Zhuang… - …, 2022 - ui.adsabs.harvard.edu
Background. Although some improvements in the management of pancreatic cancer (PC)
have been made, no major breakthroughs in terms of biomarker discovery or effective …

Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of …

Z Li, Z Ma, Q Zhou, S Wang, Q Yan, H Zhuang, Z Zhou… - Heliyon, 2022 - europepmc.org
Background Although some improvements in the management of pancreatic cancer (PC)
have been made, no major breakthroughs in terms of biomarker discovery or effective …

[HTML][HTML] Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of …

Z Li, Z Ma, Q Zhou, S Wang, Q Yan, H Zhuang, Z Zhou… - Heliyon, 2022 - ncbi.nlm.nih.gov
Background Although some improvements in the management of pancreatic cancer (PC)
have been made, no major breakthroughs in terms of biomarker discovery or effective …

[PDF][PDF] Identification By Genetic Algorithm Optimized Back Propagation Artificial Neural Network and Validation of A Four-Gene Signature for Diagnosis and Prognosis …

Z Li, S Huang, Z Ma, D Xia, Y Cai, J Wu, H Zhuang… - scholar.archive.org
Background: Although some improvements in the management of pancreatic cancer (PC)
have been made, no major breakthroughs in terms of biomarker discovery or effective …

Identification By Genetic Algorithm Optimized Back Propagation Artificial Neural Network and Validation of A Four-Gene Signature for Diagnosis and Prognosis of …

Z Li, S Huang, Z Ma, D Xia, Y Cai, J Wu, H Zhuang… - 2021 - europepmc.org
Background: Although some improvements in the management of pancreatic cancer (PC)
have been made, no major breakthroughs in terms of biomarker discovery or effective …

Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of …

Z Li, Z Ma, Q Zhou, S Wang, Q Yan, H Zhuang… - …, 2022 - ui.adsabs.harvard.edu
Background. Although some improvements in the management of pancreatic cancer (PC)
have been made, no major breakthroughs in terms of biomarker discovery or effective …